SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurogen (NRGN)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
523 35 0 NRGN
Emcee:  Terry McCormick Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
448Speaking of Aplindore for RLS, here's a nice overview of the condition, and tuck-12/27/2006
447>>Neurogen Closes $40 Million Registered Direct Offering of Common Stock Ftuck-12/22/2006
446Hi Rick...Newbie to Neurogen.Took a Quick look. R you int in Aplindore, partial dr.praveen-12/21/2006
445welcome aboard. Have been holding a small position for a long time now patientlmopgcw-12/21/2006
444I'm a shareholder again, for the first time in ages. Starter position. Shoscaram(o)uche-12/20/2006
443>>Neurogen Raises $40 Million In Registered Direct Offering of Common Stoctuck-12/19/2006
442Neurogen In-licenses Drug Candidate for Parkinson's Disease and Restless Legkeokalani'nui-11/28/2006
441Neurogen Announces Phase I Clinical Trial for Proprietary Obesity Drug Monday Nomopgcw-11/13/2006
440Neurogen Corporation Announces Third Quarter 2006 Financial Results Friday Novemmopgcw-11/3/2006
439>>Neurogen Announces Start of Phase II Proof-of-Concept Trial for Investigtuck-11/1/2006
438Neurogen Corporation Announces Second Quarter 2006 Financial Results Thursday Aumopgcw-8/4/2006
437Having now listened to the CC, the 20mg dose had too much sedation and dizzinessNeuroInvestment-5/11/2006
436IF the results at 20mg can be replicated, without increased AEs, abuse risk, or NeuroInvestment-5/11/2006
435>>So much money being invested in sleep drugs, have to wonder when the retnigel bates-5/11/2006
434369 patients. 6.6 minutes to persistent sleep high dose. Whoa. Good going nrgkeokalani'nui-5/11/2006
433Don't take it on your way to bed :-) No data on if it keeps you asleep thrkrw-5/11/2006
432Possible use in general anaethesia <gg> ?nigel bates-5/11/2006
431LPS times are extraordinary.rkrw-5/11/2006
430Neurogen Announces Positive Phase II Clinical Trial Results for Insomnia Drug Thnigel bates-5/11/2006
429Yahoo! My Yahoo! Mail Make Yahoo! your home page Sign In New User?Smopgcw-5/4/2006
428>> still patiently holding... << If there's ONE company that descaram(o)uche-1/7/2006
427Small molecule drug development, both proprietary and partnered with Pfizer, Mermopgcw-1/7/2006
426Neurogen Announces Results of Phase I Multiple Ascending Dose Trial for Insomniamopgcw-12/13/2005
425Neurogen Corporation Announces Third Quarter 2005 Financial Results Tuesday Novemopgcw-11/9/2005
424Corgentech, through its merger with AlgoRx, has a VR1 program in PII: >>Atuck-9/26/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News